Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus
            NPH Insulin during Pregnancy

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="649070.fig.003a" src="https://static.hindawi.com/articles/ogi/volume-2012/649070/figures/649070.fig.003a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Neonatal hypoglycemia</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="649070.fig.003b" src="https://static.hindawi.com/articles/ogi/volume-2012/649070/figures/649070.fig.003b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Neonatal ICU admission</td></tr></table></td></tr><tr class="fig-image" id="c"><td><img alt="649070.fig.003c" src="https://static.hindawi.com/articles/ogi/volume-2012/649070/figures/649070.fig.003c.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(c) </b>Congenital malformations</td></tr></table></td></tr><tr class="fig-image" id="d"><td><img alt="649070.fig.003d" src="https://static.hindawi.com/articles/ogi/volume-2012/649070/figures/649070.fig.003d.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(d) </b>Macrosomia</td></tr></table></td></tr></table>

<table>Meta-analysis results for neonatal outcomes.</table>

Obstetrics and Gynecology International

fig3

Figure 3

Figure 3: Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus
            NPH Insulin during Pregnancy 

Figure 3 | Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus
            NPH Insulin during Pregnancy 

Obstetrics and Gynecology International

Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy

Figure 3